Go to the first Law360 article
Go to the second Law360 article
Go to the Daily Business Review article
Go to the Daily Report article
Go to the STAT article
Go to the Top Class Actions article
- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
News & Insights
In the News
September 19, 2023 - Source: Law360, Daily Business Review, Daily Report, STAT and Top Class Actions
Charles Spalding, Brian Miller, Joe Akrotirianakis, Aaron Craig, Bruce Baber and Nicole Bronnimann represent Eli Lilly in a dispute with spas and other retailers that are allegedly selling counterfeit or compounded versions of its new drug Mounjaro
Featured Lawyers
Charles Spalding, Jr. (Charlie)
Atlanta
Brian P. Miller
Miami
Joseph Akrotirianakis (Joe)
Los Angeles
Aaron Craig
Los Angeles
Bruce W. Baber
New York
Nicole Bronnimann
Houston
Close
Featured Lawyers
Charles Spalding, Jr. (Charlie)
Atlanta
Brian P. Miller
Miami
Joseph Akrotirianakis (Joe)
Los Angeles
Aaron Craig
Los Angeles
Bruce W. Baber
New York
Nicole Bronnimann
Houston